Dr. Evan Kovac is a fellowship-trained academic urologic oncologist and Associate Professor of Urology at Rutgers New Jersey Medical School, where he also serves as Associate Program Director of the Urology Residency and Director of Urologic Oncology at University Hospital in Newark, NJ. His clinical and research expertise centers on advanced diagnostics and therapeutics for prostate and bladder cancer, including MRI/ultrasound fusion-guided transperineal prostate biopsy, PSMA PET imaging, robotic surgery, and novel intravesical therapies. Dr. Kovac is actively engaged in medical education, clinical trials, and multi-institutional collaborative research, and serves on national and international committees, including the American Urological Association (AUA) and the Société Internationale d’Urologie (SIU). He has authored numerous peer-reviewed publications and regularly presents at national and international conferences. His ongoing work integrates cutting-edge technologies such as augmented reality simulation and artificial intelligence to enhance surgical training and cancer care delivery.
Rutgers Cancer Institute of New Jersey
Newark, New Jersey, USA
Urology